Vitals

Does a new Alzheimer’s study hold the secret to early diagnosis?


Alzheimer Disease Alzheimer disease as a neuropathology memory loss due to brain degeneration and decline as a surreal medical neurology illness concept.
By Shanley Pierce | March 4, 2019

Early detection of Alzheimer’s would be the holy grail for aging Americans, as one in 10 people age 65 and older is afflicted with the degenerative brain disease. After decades of costly clinical trials, however, Alzheimer’s research remains riddled with setbacks and failures.

But in February, researchers in Europe and Australia published a study in Science Advances that showed 10 different plasma proteins helped determine which people are likely to develop Alzheimer’s. Individuals with high levels of beta-amyloid in their brains— a protein fragment that accumulates and kills brain cells— were classified as having preclinical Alzheimer’s.

The study, which compared 238 cognitively healthy individuals, offers a glimmer of hope in a field with no survivors.

How could this study improve the detection and treatment of Alzheimer’s in the future?

Previous generations assumed that if individuals were cognitively unimpaired, they didn’t have beta-amyloid in their brains. However, positron emission tomography (PET) scans debunked that notion. Researchers can now capture high-quality images of amyloid plaques in the brain and show the presence of beta-amyloid even in the brains of cognitively healthy patients.

Currently, scientists use PET imaging and cerebrospinal fluid to identify biomarkers in the blood for Alzheimer’s. However, PET imaging is highly expensive and is only available at specialized centers. Spinal taps to extract cerebrospinal fluid, though less expensive, are extremely painful for patients.

A blood test to screen for preclinical Alzheimer’s—much like routine blood tests to measure cholesterol or glucose levels—could be inexpensive and widely available.

“It would be nice if we could draw a blood test when you’re 50 or 60, monitor you every five years, be alerted of your amyloid levels, and [prescribe] a pill or infusion that’s going to help stave off Alzheimer’s,” said Joseph Shimon Kass, M.D., director of neurology at Baylor College of Medicine’s Alzheimer’s Disease and Memory Disorders Center. “We’re nowhere near that, but this study brings us closer to that possibility.”

Given that biological changes occur in the brain 10 to 20 years before there are any clinical symptoms of Alzheimer’s, early detection could also help alleviate the economic burden the disease weighs on the health care system.

“Financially, if all Americans today who have Alzheimer’s or who will get Alzheimer’s were diagnosed in the mild cognitive impairment stage (before they develop full-blown dementia), it could collectively save up to $7.9 trillion in health and long-term care cost,” said Julie Kutac, Ph.D., professional education and research specialist at the Alzheimer’s Association’s Houston & Southeast Texas Chapter.

How is the new blood test different?

Researchers claim that theirs is the first study to consistently use non-targeted techniques to analyze any protein that could potentially serve as a biomarker throughout the different phases of testing. Instead of searching for specific proteins researchers believe are associated with Alzheimer’s, a non-targeted approach can measure many more proteins.

Scientists found 560 proteins associated with beta-amyloid pathology, then narrowed it down to 10 proteins that helped them determine which cognitively unimpaired individuals in the study had high enough levels of beta-amyloid in their brains to qualify as preclinical Alzheimer’s.

What are the caveats of the new study?

This test “probably has some value,” said Joseph C. Masdeu, M.D., Ph.D., director of the Houston Methodist Nantz National Alzheimer Center, but additional studies with larger sample groups will need to be performed to validate these claims.

The European group consisted of 59 participants who were beta-amyloid negative and 35 who were beta-amyloid positive. The Australian group consisted of 100 participants who were beta-amyloid negative and 44 who were beta-amyloid positive.

Although the test had an overall accuracy of 89 percent and positive predictive value (meaning the chances that a patient receives a positive result) of 85 percent, the test groups were too small to make any profound pronouncements.

Nonetheless, this study is a step in the right direction.

“Research on this disease is moving faster now than ever before,” Masdeu said. “The data is coming in very quickly and, with it, the hope that we will very soon have something that we can offer our patients as a treatment.”




Social Posts

profile_image

Houston Methodist

@MethodistHosp

@SilkRoadMed We appreciate the shout-out.

15 mins ago
profile_image

University of Houston

@UHouston

RT @UHCougarMBK: .@UHouston coming in at No 25 this week#ForTheCity #GoCoogs

27 mins ago
profile_image

University of Houston

@UHouston

RT @UHcheerleading: Today, we honor the life and legacy of Dr. Martin Luther King, Jr. His message will always be one of love, compassion…

28 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

#Prostatecancer risk factors include: -being over the age of 50 -family history -diet Learn more: https://t.co/PQ77F2XysX #CancerMoonshot #endcancer

52 mins ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

As we reflect this #MLKDay, we hope to continue his legacy through caring for our communities, helping our neighbors, and sharing his message with others. https://t.co/phuNnJeQWG

55 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veteran awaiting heart transplant sang to lift others https://t.co/iBWkXD2gAZ via #VAntagePoint

1 hour ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Inspired by the support she received during #uterinecancer treatment and a new perspective on life, Callie Glaves is exploring ways to give back to others: https://t.co/j51l5j8b2j @PamSolimanMD #gyncsm #endcancer

3 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today’s #VeteranOfTheDay is Marine Veteran Arthur Roland Keller, who served in a WWI machine gun battalion at the Battle of Soissons: https://t.co/zhtwsuYoDM

3 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceEngineering: Today we honor and celebrate the life and work of Dr. Martin Luther King Jr. so that we may keep his dream alive forev…

4 hours ago
profile_image

TexasHeartInstitute

@Texas_Heart

"Many older adults don't get needed cardiac rehab after a heart attack," says a new study. https://t.co/sIlmV5VCRd via @Reuters https://t.co/XbCCl5QHDF

5 hours ago
profile_image

Memorial Hermann

@memorialhermann

Even though Dana was just three when she first arrived at TIRR Memorial Hermann for polio treatment, she remembers it clearly. Nearly five decades after her treatment as a child, Dana returned. Read why: https://t.co/PJ1jfOqn2O.

5 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@totalq8y2 Hi there, please see our response to your direct message. Best wishes to you.

5 hours ago
profile_image

Harris Health System

@harrishealth

A sliced apple versus a slice of apple pie. If it were a healthy choice contest, fresh fruit would certainly win. But many of us may find it hard to resist that sweet treat. To help you eat better, try the following simple steps. https://t.co/nAQHDZhmXI https://t.co/1AcQaEk6W8

5 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

In recognition of Dr. King’s incredible legacy of service and leadership to gain equality for all Americans, Congress designated #MLK federal holiday as a national day of service. #MLKDay is a chance to honor his life and re-commit ourselves to serving our communities. https://t.co/XbzfO3k6o8

5 hours ago
profile_image

University of Houston

@UHouston

Campus is closed today in honor of #MLKDay. Celebrate Dr. King's life and legacy with UH: https://t.co/ZKWf16ih45 https://t.co/ZXdr2MFaN0

8 hours ago